Quantbot Technologies LP Makes New Investment in Omega Healthcare Investors, Inc. $OHI

Quantbot Technologies LP bought a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI) during the second quarter, HoldingsChannel reports. The institutional investor bought 14,471 shares of the real estate investment trust’s stock, valued at approximately $690,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in Omega Healthcare Investors in the second quarter valued at approximately $1,838,155,000. Bank of New York Mellon Corp purchased a new stake in Omega Healthcare Investors in the second quarter worth $275,230,000. Norges Bank bought a new stake in shares of Omega Healthcare Investors in the fourth quarter valued at $156,166,000. Invesco Ltd. raised its stake in shares of Omega Healthcare Investors by 101.7% in the third quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock valued at $208,775,000 after buying an additional 2,493,877 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of Omega Healthcare Investors during the 4th quarter valued at $93,476,000. 65.25% of the stock is owned by institutional investors.

Omega Healthcare Investors Stock Down 1.5%

Shares of NYSE OHI opened at $46.29 on Friday. The company has a market cap of $14.03 billion, a P/E ratio of 16.53, a P/E/G ratio of 1.90 and a beta of 0.57. Omega Healthcare Investors, Inc. has a 52 week low of $39.26 and a 52 week high of $52.39. The business has a 50-day simple moving average of $48.32 and a two-hundred day simple moving average of $47.09.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.68. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%.The firm had revenue of $328.25 million for the quarter, compared to analysts’ expectations of $266.97 million. During the same period in the prior year, the business posted $0.77 earnings per share. The company’s revenue was up 16.2% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. Equities research analysts anticipate that Omega Healthcare Investors, Inc. will post 3.12 EPS for the current year.

Omega Healthcare Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Monday, August 3rd were paid a dividend of $0.68 per share. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.67. This represents a $2.72 annualized dividend and a yield of 5.9%. The ex-dividend date of this dividend was Monday, August 3rd. Omega Healthcare Investors’s dividend payout ratio is presently 97.14%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on OHI shares. Royal Bank Of Canada increased their price target on Omega Healthcare Investors from $47.00 to $48.00 and gave the stock a “sector perform” rating in a research note on Monday, May 4th. Raymond James Financial started coverage on Omega Healthcare Investors in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $50.00 price objective on the stock. Scotiabank dropped their price objective on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Barclays began coverage on shares of Omega Healthcare Investors in a research report on Tuesday, July 7th. They set an “underweight” rating and a $51.00 target price for the company. Finally, Citigroup lifted their target price on shares of Omega Healthcare Investors from $52.00 to $58.00 and gave the stock a “buy” rating in a research note on Tuesday, August 4th. Six analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $49.21.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.